These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 2767744

  • 21. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair.
    Majsterek I, Sliwinski T, Poplawski T, Pytel D, Kowalski M, Slupianek A, Skorski T, Blasiak J.
    Mutat Res; 2006 Jan 31; 603(1):74-82. PubMed ID: 16388976
    [Abstract] [Full Text] [Related]

  • 22. Enhancement of etoposide and methotrexate sensitivity by indomethacin in vitro.
    Maca RD.
    Anticancer Drug Des; 1991 Nov 31; 6(5):453-66. PubMed ID: 1722410
    [Abstract] [Full Text] [Related]

  • 23. Sensitization of P388 murine leukemia cells to epirubicin cytotoxicity by reserpine.
    Viladkar A, Chitnis M.
    Cancer Biother; 1993 Nov 31; 8(1):77-85. PubMed ID: 7812352
    [Abstract] [Full Text] [Related]

  • 24. Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugs.
    Tipping AJ, Mahon FX, Zafirides G, Lagarde V, Goldman JM, Melo JV.
    Leukemia; 2002 Dec 31; 16(12):2349-57. PubMed ID: 12454739
    [Abstract] [Full Text] [Related]

  • 25. Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis.
    Fruehauf S, Topaly J, Buss EC, Fischer T, Ottmann OG, Emmerich B, Müller MC, Schuld P, Balleisen L, Hehlmann R, Ho AD, Hochhaus A.
    Cancer; 2007 Apr 15; 109(8):1543-9. PubMed ID: 17340589
    [Abstract] [Full Text] [Related]

  • 26. The novel pyrrolo-1,5-benzoxazepine, PBOX-21, potentiates the apoptotic efficacy of STI571 (imatinib mesylate) in human chronic myeloid leukaemia cells.
    Bright SA, Greene LM, Greene TF, Campiani G, Butini S, Brindisi M, Lawler M, Meegan MJ, Williams DC, Zisterer DM.
    Biochem Pharmacol; 2009 Feb 01; 77(3):310-21. PubMed ID: 19014913
    [Abstract] [Full Text] [Related]

  • 27. Modulation of sensitivity to mitoxantrone in human chronic myeloid leukemia cells by the antidepressant sintamil.
    Chitnis MP, Satyamoorthy K, Pradhan SG, Advani SH.
    Oncology; 1988 Feb 01; 45(4):292-6. PubMed ID: 3164462
    [Abstract] [Full Text] [Related]

  • 28. [Modulation of adriamycin cytotoxicity on K 562 and K562adri cells by interferon alpha and/or all-trans-retinoic acid].
    Dufour P, Feugeas O, Bergerat JP, Oberling F.
    Bull Cancer; 1994 Oct 01; 81(10):894-6. PubMed ID: 7734774
    [Abstract] [Full Text] [Related]

  • 29. Molecular remission in Philadelphia-positive adult acute lymphoblastic leukaemia rapidly induced by conventional-dose chemotherapy.
    Irving JA, Finney R, Lennard A, Proctor SJ.
    Bone Marrow Transplant; 1998 Feb 01; 21(3):323-5. PubMed ID: 9489662
    [Abstract] [Full Text] [Related]

  • 30. A sequential blockade strategy for the design of combination therapies to overcome oncogene addiction in chronic myelogenous leukemia.
    Chen R, Gandhi V, Plunkett W.
    Cancer Res; 2006 Nov 15; 66(22):10959-66. PubMed ID: 17108134
    [Abstract] [Full Text] [Related]

  • 31. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X, Jin Y, Cheng C, Zhang H, Zou W, Zheng Q, Lu Z, Chen Q, Lai Y, Pan J.
    Clin Cancer Res; 2009 Mar 01; 15(5):1686-97. PubMed ID: 19240172
    [Abstract] [Full Text] [Related]

  • 32. Sequential treatment with flavopiridol synergistically enhances pyrrolo-1,5-benzoxazepine-induced apoptosis in human chronic myeloid leukaemia cells including those resistant to imatinib treatment.
    Bright SA, Campiani G, Deininger MW, Lawler M, Williams DC, Zisterer DM.
    Biochem Pharmacol; 2010 Jul 01; 80(1):31-8. PubMed ID: 20206141
    [Abstract] [Full Text] [Related]

  • 33. Cladribine combined with mitoxantrone in the treatment of blastic phase of chronic myeloid leukemia.
    Robak T, Góra-Tybor J.
    Neoplasma; 2001 Jul 01; 48(3):203-7. PubMed ID: 11583290
    [Abstract] [Full Text] [Related]

  • 34. Circumvention of drug resistance of P388/R cells by the combination of adriamycin and mitoxantrone with hyperthermia (42 degrees C).
    Juvekar AS, Chitnis MP.
    Neoplasma; 1991 Jul 01; 38(2):207-11. PubMed ID: 2041579
    [Abstract] [Full Text] [Related]

  • 35. Combination treatment of imatinib-sensitive and -resistant BCR-ABL-positive CML cells with imatinib and farnesyltransferase inhibitors.
    Radujkovic A, Topaly J, Fruehauf S, Zeller WJ.
    Anticancer Res; 2006 Jul 01; 26(3A):2169-77. PubMed ID: 16827161
    [Abstract] [Full Text] [Related]

  • 36. [In vitro effect of combined use of BH-AC and nitrosourea derivatives against adriamycin-resistant human leukemia cell line].
    Oguro M, Sakai C, Takagi T, Matsuura Y.
    Gan To Kagaku Ryoho; 1991 Nov 01; 18(14):2403-8. PubMed ID: 1952959
    [Abstract] [Full Text] [Related]

  • 37. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS, Liu DS, Dai CW, Li RJ.
    Am J Hematol; 2006 Apr 01; 81(4):242-55. PubMed ID: 16550520
    [Abstract] [Full Text] [Related]

  • 38. Anti-leukemic activity of valproic acid and imatinib mesylate on human Ph+ ALL and CML cells in vitro.
    Kircher B, Schumacher P, Petzer A, Hoflehner E, Haun M, Wolf AM, Nachbaur D, Gastl G.
    Eur J Haematol; 2009 Jul 01; 83(1):48-56. PubMed ID: 19226363
    [Abstract] [Full Text] [Related]

  • 39. Modification of adriamycin-induced cytotoxicity by recombinant human interferon-gamma and/or verapamil in human stomach cancer cells.
    Hong WS, Kim CM, Lee CT, Lee JO, Kang TW.
    J Korean Med Sci; 1992 Sep 01; 7(3):236-40. PubMed ID: 1285922
    [Abstract] [Full Text] [Related]

  • 40. Enhanced anti-proliferative action of busulphan by quercetin on the human leukaemia cell line K562.
    Hoffman R, Graham L, Newlands ES.
    Br J Cancer; 1989 Mar 01; 59(3):347-8. PubMed ID: 2930697
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.